Eureka Alert

IMAGE: This is Brian C. Capell, MD, PhD. view more 

Credit: Penn Medicine

PHILADELPHIA – Brian C. Capell, MD, PhD, an assistant professor of Dermatology in the Perelman School of Medicine at the University of Pennsylvania, a core faculty member of the Penn Epigenetics Institute, and a member of the Abramson Cancer Center, has been awarded a prestigious Damon Runyon Clinical Investigator Award for 2018. The award comes with a $450,000 unrestricted research grant over three years. Capell will use the funds to continue his research into epigenetic targets in the skin, specifically in hopes of developing effective therapies for squamous cell carcinoma – a common form of cancer that most often develops in the skin. Capell is one of just six researchers in the United States to receive the award this year.

The Damon Runyon Cancer Research Foundation selects the Clinical Investigator Award winners at its spring 2018 Clinical Investigator Award Committee review. The recipients are outstanding early career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation’s leading scientists and clinicians.

The Clinical Investigator Award program is specifically intended to help address the shortage of physicians capable of translating scientific discovery


Article originally posted at

Click here for the full story

CategoryAggregator News

Privacy Policy / Terms Of Use

Powered by MMD